EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Enhancing IgA-mediated neutrophil cytotoxicity against neuroblastoma by CD47 blockade

Chilam Chan iD, Marjolein Stip iD, Maaike Nederend, Marco Jansen, Elsemieke Passchier, Femke van den Ham, Judith Wienke, Geert van Tetering, Jeanette Leusen iD

Journal for ImmunoTherapy of Cancer · 2024

DOI: 10.1136/jitc-2023-008478 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal for ImmunoTherapy of Cancer, 2024. Verfasst von Chilam Chan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Center for Translational Immunology, UMC Utrecht, Utrecht, The Netherlands. Hauptthemen laut MEDLINE: CD47 Antigen, Neuroblastoma, Neutrophils, Immunoglobulin A. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: KWF Kankerbestrijding, Stichting Villa Joep.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Approximately half of the neuroblastoma patients develop high-risk neuroblastoma. Current treatment involves a multimodal strategy, including immunotherapy with dinutuximab (IgG ch14.18) targeting GD2. Despite achieving promising results, the recurrence rate remains high and poor survival persists. The therapeutic efficacy of dinutuximab is compromised by suboptimal activation of neutrophils and severe neuropathic pain, partially induced by complement activation.

Methods

To enhance neutrophil cytotoxicity, IgG ch14.18 was converted to the IgA isotype, resulting in potent neutrophil-mediated antibody-dependent cell-mediated cytotoxicity (ADCC), without complement activation. However, myeloid checkpoint molecules hamper neutrophil cytotoxicity, for example through CD47 that is overexpressed on neuroblastomas and orchestrates an immunosuppressive environment upon ligation to signal regulatory protein alpha (SIRPα) expressed on neutrophils. In this study, we combined IgA therapy with CD47 blockade.

Results

In vitro killing assays showed enhanced IgA-mediated ADCC by neutrophils targeting neuroblastoma cell lines and organoids in comparison to IgG. Notably, when combined with CD47 blockade, both IgG and IgA therapy were enhanced, though the combination with IgA resulted in the greatest improvement of ADCC. Furthermore, in a neuroblastoma xenograft model, we systemically blocked CD47 with a SIRPα fusion protein containing an ablated IgG1 Fc, and compared IgA therapy to IgG therapy. Only IgA therapy combined with CD47 blockade increased neutrophil influx to the tumor microenvironment. Moreover, the IgA combination strategy hampered tumor outgrowth most effectively and prolonged tumor-specific survival.

Conclusion

These promising results highlight the potential to enhance immunotherapy efficacy against high-risk neuroblastoma through improved neutrophil cytotoxicity by combining IgA therapy with CD47 blockade.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CD47 AntigenNeuroblastomaNeutrophilsImmunoglobulin AHumansAnimalsMiceCell Line, TumorAntibody-Dependent Cell CytotoxicityAntibodies, MonoclonalXenograft Model Antitumor AssaysImmunotherapyFemaleAntineoplastic Agents, Immunological

Stichwörter der Autor:innen

immune checkpoint inhibitorsimmunotherapyneuroblastomaneutrophil infiltration

Substanzen

CD47 AntigenCD47 protein, humanImmunoglobulin AdinutuximabAntibodies, MonoclonalAntineoplastic Agents, Immunological

Autor:innen und Institutionen

  • Center for Translational Immunology, UMC Utrecht, Utrecht, The Netherlands.
  • Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands.
  • Center for Translational Immunology, UMC Utrecht, Utrecht, The Netherlands j.h.w.leusen@umcutrecht.nl.

ORCID-Profile: Chilam Chan, Marjolein Stip, Jeanette Leusen

Förderung

  • KWF Kankerbestrijding
  • Stichting Villa Joep

Zitieren

APA

Chan, C., Stip, M., Nederend, M., Jansen, M., Passchier, E., van den Ham, F., Wienke, J., van Tetering, G., & Leusen, J. (2024). Enhancing IgA-mediated neutrophil cytotoxicity against neuroblastoma by CD47 blockade. Journal for ImmunoTherapy of Cancer. https://doi.org/10.1136/jitc-2023-008478

Vancouver

Chan C, Stip M, Nederend M, Jansen M, Passchier E, van den Ham F, et al. Enhancing IgA-mediated neutrophil cytotoxicity against neuroblastoma by CD47 blockade. Journal for ImmunoTherapy of Cancer. 2024. doi:10.1136/jitc-2023-008478

BibTeX
@article{Chan2024,
  author = {Chan, Chilam and Stip, Marjolein and Nederend, Maaike and Jansen, Marco and Passchier, Elsemieke and van den Ham, Femke and Wienke, Judith and van Tetering, Geert and Leusen, Jeanette},
  title = {Enhancing IgA-mediated neutrophil cytotoxicity against neuroblastoma by CD47 blockade},
  journal = {Journal for ImmunoTherapy of Cancer},
  year = {2024},
  doi = {10.1136/jitc-2023-008478}
}
Kostenlos starten →